Stay updated on Ipragliflozin vs Sitagliptin in T2DM with SU+Met Clinical Trial

Sign up to get notified when there's something new on the Ipragliflozin vs Sitagliptin in T2DM with SU+Met Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ipragliflozin vs Sitagliptin in T2DM with SU+Met Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-16T11:18:11.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added and Revision: v3.4.3 was removed.
    Difference
    0.1%
    Check dated 2026-03-18T20:51:46.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    Metadata updates include adding the topic 'Type 2 diabetes' and the related topic 'MedlinePlus Genetics', and the site revision updated from v3.4.2 to v3.4.3.
    Difference
    0.2%
    Check dated 2026-03-11T17:28:39.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    Removed 'Type 2 diabetes' and 'MedlinePlus Genetics' from the Related Topics section.
    Difference
    0.2%
    Check dated 2026-03-04T13:30:49.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    Added related topics: Type 2 diabetes and MedlinePlus Genetics.
    Difference
    0.2%
    Check dated 2026-02-25T09:24:15.000Z thumbnail image
  8. Check
    60 days ago
    Change Detected
    Summary
    The page no longer lists 'Type 2 diabetes' as a condition and removes the related topic 'MedlinePlus Genetics'.
    Difference
    0.2%
    Check dated 2026-02-18T07:30:16.000Z thumbnail image

Stay in the know with updates to Ipragliflozin vs Sitagliptin in T2DM with SU+Met Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ipragliflozin vs Sitagliptin in T2DM with SU+Met Clinical Trial page.